Q-Line Biotech IPO

About Q-Line Biotech Company

Q-Line Biotech was established in 2013 and has evolved from an import-led diagnostics business into an Indian manufacturer and distributor of in-vitro diagnostic solutions with a broader portfolio over time. Its core focus is on developing, manufacturing, marketing, and supplying reagents, consumables, rapid tests, IVD devices, and pathology equipment, with expertise spanning biochemistry, hematology, immunodiagnostics, molecular assays, lateral flow tests, ELISA, and point-of-care products. The company highlights strengths in indigenous product development, ISO-certified manufacturing, technology transfer for instrument production, and quality-focused after-sales support, while serving diagnostic service providers, hospitals, medical colleges, pathology labs, CROs, and other healthcare customers across India and export markets. Its operating approach emphasizes accessibility, affordability, and timely delivery, with an innovation-led mindset aimed at addressing regulatory, quality, and supply-chain demands in diagnostics.